|
Henry J. Esber, Ph.D. is a Senior Consultant, Business Development, at Charles River Laboratories, Preclinical. He is the co-founder of BioSignature Diagnostics, Inc. and Advanced Drug Delivery, Inc. He also serves on the Scientific Advisory Boards of several biotechnology companies and is the author of over 130 technical publications. Dr. Esber has more than 25 years of experience in the areas of Oncology/Tumor Immunology and Immunotherapy as well as strong knowledge in the field of Toxicology and Regulatory Affairs. Dr. Esber received a B.S. degree in biology/Pre-Med from the College of William and Mary, an M.S. degree in Public Health and Parasitology from the University of North Carolina, and a Ph.D. in Immunology/Microbiology from West Virginia University Medical Center..
| 